微信公众号

官网二维码

中国癌症防治杂志 ›› 2023, Vol. 15 ›› Issue (1): 56-61.doi: 10.3969/j.issn.1674-5671.2023.01.09

• 临床研究 • 上一篇    下一篇

基于SEER数据库分析儿童、青少年及年轻成年霍奇金淋巴瘤患者第二原发恶性肿瘤的发生情况及其危险因素

  

  1. 中国中医科学院广安门医院;北京中医药大学研究生院;北京中医药大学中医学院
  • 出版日期:2023-02-25 发布日期:2023-03-01
  • 通讯作者: 刘杰 E-mail:dr.liujie@163.com
  • 基金资助:
    首都临床特色应用研究项目(Z181100001718175);中国中医科学院科技创新工程(CI2021A05502)

Analysis of  occurrence and risk factors of second malignant neoplasms in children, adolescents and young adult patients with Hodgkin lymphoma based on SEER database

  • Online:2023-02-25 Published:2023-03-01

摘要: 目的 探讨儿童、青少年及年轻成年霍奇金淋巴瘤患者第二原发恶性肿瘤(second malignant neoplasms,SMNs)的发生情况及其危险因素,指导健康筛查策略。方法 收集1985年1月至2019年12月SEER数据库中诊断为霍奇金淋巴瘤的儿童、青少年及其年轻成年患者的病例资料,回顾性分析患者的人口学特征、临床特征与SMNs发生情况,采用单因素、多因素Cox风险回归分析其危险因素。结果 从SEER数据库共筛选了25 529例霍奇金淋巴瘤患者,平均年龄为25岁,90.4%(23 071/25 529)为经典型霍奇金淋巴瘤,临床分期为Ⅱ期的患者占48.5%(12 387/25 529);1 457例(5.7%)发生SMNs,以生殖系统肿瘤(27.5%)、血液及免疫器官肿瘤(17.7%)、头颈部肿瘤(16.3%)为主。多因素Cox回归显示,女性(HR=1.465,95%CI:1.319~1.628,P<0.001)、年龄较大(21~25岁:HR=1.259,95%CI:1.069~1.482,P=0.006;26~30岁:HR=1.315,95%CI:1.116~1.548,P=0.001;31~39岁:HR=2.034,95%CI:1.765~2.344,P<0.001)、放疗(HR=1.128,95%CI:1.011~1.260,P=0.032)是影响SMNs发生的独立危险因素。结论 儿童、青少年及年轻成年霍奇金淋巴瘤幸存者罹患SMNs的风险在治疗后持续存在,综合性别、年龄、放疗情况的SMNs危险因素,平衡治疗生存获益与SMNs风险,可指导霍奇金淋巴瘤患者治疗后的随访与SMNs筛查。

关键词: Objective To investigate the occurrence and risk factors of second malignant neoplasms (SMNs) in children, adolescents and young adult patients with Hodgkin lymphoma, and to guide health screening strategies. Methods , The data of children, adolescents and young adults diagnosed with Hodgkin lymphoma were collected from the SEER database from January 1985 to December 2019, and the demographic characteristics, clinical features and the occurrence of SMNs were retrospectively analyzed. Univariable and multivariable Cox risk regression were used to analyze the risk factors. Results A total of 25, 529 patients with Hodgkin lymphoma were screened from the SEER database, the mean age was 25 years, 90.4%(23, 071/25, 529) had Classical Hodgkin lymphoma, and 48.5% (12 387/25 529) with clinical stage Ⅱ. SMNs occurred in 1 457 cases (5.7%), mainly in reproductive organ tumors (27.5%), hematologic/immunological organ tumors (17.7%) and head/neck tumors (16.3%). Multivariable Cox regression showed that female (HR=1.465, 95%CI: 1.319-1.628, P<0.001), older patients (21-25 years: HR=1.259, 95%CI: 1.069-1.482, P=0.006, 26-30 years: HR=1.315, 95%CI: 1.116-1.548, P=0.001, 31-39 years: HR=2.034, 95%CI: 1.765-2.344, P<0.001), radiotherapy (HR=1.128, 95CI: 1.011-1.260, P=0.032) were independent risk factors affecting the occurrence of SMNs. Conclusions The risk of SMNs persists after treatment in children, adolescents and young adult with Hodgkin lymphoma. To guide the follow-up and SMNs screening of Hodgkin lymphoma patients after treatment, it is necessary to pay attention to the SMNs risk factors (gender, age and radiotherapy) and balance the survival benefit of treatment with the risk of SMNs.

Abstract: 霍奇金淋巴瘤;第二原发恶性肿瘤;年轻患者;危险因素

Key words: 霍奇金淋巴瘤, 第二原发恶性肿瘤, 年轻患者, 危险因素

中图分类号: 

  • Hodgkin lymphoma